GRIN2A blocking peptide product blog
Tags: Blocking Peptide; GRIN2A; GRIN2A blocking peptide;
The GRIN2A grin2a (Catalog #MBS9218353) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The GRIN2A grin2a product has the following accession number(s) (GI #14285603) (NCBI Accession #Q12879.1) (Uniprot Accession #Q12879). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
NMDA receptor subtype of glutamate-gated ion channels possesses high calcium permeability and voltage-dependent sensitivity to magnesium. Activation requires binding of agonist to both types of subunits.
Cellular Location: Cell membrane; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. GRIN2A also interacts with the following gene(s): CAMK2G, DLG4, GRIN1, SRC. Brain Diseases, Epilepsy, Epilepsy, Rolandic, Landau-Kleffner Syndrome, Melanoma, Movement Disorders, Nervous System Diseases, Neurobehavioral Manifestations, Seizures, Speech Disorders are some of the diseases may be linked to GRIN2A Antibody (C-term) Blocking peptide. Blood, Brain, Embryonic Tissue, Eye, Kidney, Liver, Muscle, Skin tissues are correlated with this protein. The following patways have been known to be associated with this gene.